vitrivaxbio.com
Get leads like Vitrivaxbio — and thousands more
Build targeted lists by tech stack, traffic, and more
VitriVax: The $12M Bet on Better Vaccines
A biotech startup using particle engineering to solve global delivery challenges
In a world where 1.5 billion vaccines are wasted annually due to cold chain requirements, VitriVax isn't just making vaccines—it's solving the logistics nightmare that makes global immunization impossible. This Boston-based biotech is betting $8.8M in funding that their particle engineering platform can make vaccines survive where others fail.
"VitriVax isn't solving vaccine efficacy—they're solving vaccine accessibility, which is where the real global health crisis lies."
The Infrastructure Problem
While most biotechs chase novel antigens, VitriVax targets the Achilles' heel of vaccination: the cold chain. Their platform focuses on stabilizing vaccines at higher temperatures, effectively eliminating the need for ultra-cold storage. This isn't incremental—it's a fundamental rethinking of vaccine delivery architecture. With 63 employees and $11.9M in revenue, they're operating at a scale where technical validation meets commercial reality.
The Traffic Paradox
Here's what's fascinating: 776 monthly visits with 42% direct traffic suggests a highly targeted audience. This isn't a consumer brand—it's a B2B play where decision-makers know exactly where to find them. The 32% organic search traffic around terms like 'npj vaccines' and 'rick malley lab' reveals a scientific community actively seeking their expertise. Low volume, high intent.
The leadership team reads like a biotech dream team: Romulo Colindres (CEO), Robert Garcea (Co-Founder), Theodore Randolph (Co-Founder), plus specialized talent like Joe Spencer (Head Particle Engineering). This isn't a founder-led science project—it's a deliberate assembly of expertise spanning operations, engineering, and executive leadership.
- Particle engineering focus over antigen discovery (differentiated positioning)
- Proven revenue generation ($11.9M) despite early-stage funding ($8.8M)
- Specialized talent concentration (63 employees for $12M revenue = high technical density)
- Scientific community traction evidenced by targeted keyword traffic
The Unsexy Biotech That Might Actually Work
While competitors chase flashy novel platforms, VitriVax is methodically solving the $2B cold chain problem—revenue in hand, science in the lab, and a team that knows the difference between a publishable paper and a deployable solution.
What tech stack does Vitrivaxbio use?
How much traffic does Vitrivaxbio get?
Traffic & Engagement
Traffic Sources
Where is Vitrivaxbio's audience located?
What keywords does Vitrivaxbio rank for?
3 keywordsHow is Vitrivaxbio's SEO?
Meta Tags
VitriVax: Eliminating barriers to global vaccination
H1 Tags
What is Vitrivaxbio's revenue?
Who works at Vitrivaxbio?
Loading leads...
What do customers think of Vitrivaxbio?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Vitrivaxbio
What is Vitrivaxbio's Revenue?
How fast is Vitrivaxbio growing?
What technologies does Vitrivaxbio use?
Who are Vitrivaxbio's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Vitrivaxbio?
Social Profiles
Contact Information
Export vitrivaxbio.com Data
Download the complete tech stack, analytics, leads, and company data for vitrivaxbio.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About vitrivaxbio.com
Company Overview
vitrivaxbio.com Social Media
Contact vitrivaxbio.com
Email Addresses
Phone Numbers
Technology Stack
vitrivaxbio.com uses 14 technologies across their website including Font Awesome, Google Fonts, reCAPTCHA, PHP, and more.
Fonts
Font Awesome, Google Fonts
Security
reCAPTCHA
Programming Languages
PHP
CMS
WordPress
E-commerce & Payments
WooCommerce
Analytics & Marketing
Google Analytics
Traffic & Audience
vitrivaxbio.com receives approximately 776 monthly visitors. The website has a bounce rate of 39% with visitors viewing an average of 1.0 pages per visit. Users spend an average of 0:00 on the site.
The majority of vitrivaxbio.com's traffic comes from .
Frequently Asked Questions
What is vitrivaxbio.com?
What technologies does vitrivaxbio.com use?
How do I contact vitrivaxbio.com?
What are vitrivaxbio.com's social media accounts?
How popular is vitrivaxbio.com?
Related Searches
This page provides publicly available information about vitrivaxbio.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit vitrivaxbio.com directly at https://vitrivaxbio.com.